"Cytochrome P-450 CYP11B2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A mitochondrial cytochrome P450 enzyme that catalyzes the 18-hydroxylation of steroids in the presence of molecular oxygen and NADPH-specific flavoprotein. This enzyme, encoded by CYP11B2 gene, is important in the conversion of CORTICOSTERONE to 18-hydroxycorticosterone and the subsequent conversion to ALDOSTERONE.
Descriptor ID |
D019405
|
MeSH Number(s) |
D08.244.453.484.500 D08.244.453.915.050 D08.811.682.690.708.170.425.500 D08.811.682.690.708.170.915.050 D12.776.422.220.453.484.500 D12.776.422.220.453.915.050
|
Concept/Terms |
Cytochrome P-450 CYP11B2- Cytochrome P-450 CYP11B2
- Cytochrome P 450 CYP11B2
- Aldosterone Synthase
- Aldosterone Synthase Cytochrome P-450
- Aldosynthase
- Cytochrome P450Aldo
- P450c11AS
- Cytochrome P450 11B2
- Cytochrome P-450c11AS
- Cytochrome P 450c11AS
- CYP11B2
- Steroid 18-Hydroxylase
- Steroid 18 Hydroxylase
- CYP 11B2
|
Below are MeSH descriptors whose meaning is more general than "Cytochrome P-450 CYP11B2".
Below are MeSH descriptors whose meaning is more specific than "Cytochrome P-450 CYP11B2".
This graph shows the total number of publications written about "Cytochrome P-450 CYP11B2" by people in this website by year, and whether "Cytochrome P-450 CYP11B2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 1 | 0 | 1 |
2003 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cytochrome P-450 CYP11B2" by people in Profiles.
-
Impact of renin-angiotensin-aldosterone system gene variants on the severity of hypertension in patients with newly diagnosed hypertension. Am J Hypertens. 2003 Dec; 16(12):1006-10.
-
An aldosterone synthase gene variant is associated with improvement in left ventricular ejection fraction in dilated cardiomyopathy. Cardiovasc Res. 2002 Jun; 54(3):584-9.